History Of Cadiology

Home » Neurology

« Go Back

New York Chiropractor, Dentist Join Forces to Battle TMJ (temporomandibular joint disorder)

There is no single cure or approach, but Dr. Nick Mobilia and Dr. Steven Shoshany have found that a synergistic approach to temporomandibular joint dysfunction (TMJ) works best. The pair recently joined forces to help patients battle the condition in a rare pairing of their respective medical professions.

Castle Connolly Expands Corporate Membership to Help Small Companies Find Top Doctors

A new initiative from Castle Connolly Medical Ltd. allows the employees of smaller companies, organizations and associations to find top doctors. Previously the membership had been exclusive to large companies.

Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors

Stemedica Cell Technologies, Inc. announces leading stem cell specialist Dr Nabil Dib, MD as Special Advisor to its Board of Directors. Dr Dib is President of the International Society for Cardiovascular Translational Research (ISCTR) and Director of Cardiovascular and Stem Cell Consultants (CSCC).

Parkinson's Virtual Reality Gait Training Device Improves Quality of Life

Newly released virtual reality gait training device shown to improve quality of life for Parkinson's disease, multiple sclerosis and other movement disorders

Northeast Center for Special Care The Eyes of Wellness 2009 Calendar Showcases Artists with Brain Injury and Other Disorders

Northeast Center for Special Care presents The Eyes of Wellness, a unique 12-month calendar for 2009 showcasing the artwork of individuals with traumatic brain injury and other disorders, is now available as a free download.

GLOtoSLEEP Masks to Give Cardinals and Steelers a Super Night's Sleep at Superbowl XLIII

Santa Cruz Holistics, distributors of the GLOtoSLEEP™ mask with natural sleep-inducing technology, continues their tradition of helping celebrities get a good night's rest by providing masks to the Superbowl XLIII players and their wives.

Foundation Formed to Support Down Syndrome Research and New Encouraging Treatment Protocol

Changing Minds Foundation was formed to change the minds of the medical and scientific communities in considering a new treatment for intellectual disability associated with Down syndrome. The Foundation supports a new treatment protocol that has enabled increased capacity for learning in persons with Down syndrome. Developed by a mom whose son has Down syndrome, the treatment has enhanced the 11-year-old's skills in reading, comprehension and communication significantly. A documentary titled "Changing A Mind" filmed over two years shows the progress of 7 persons with Down syndrome on the treatment.

Columbia Doctors, the Physicians and Surgeons of Columbia University Select MxSecure, Inc., as Their Medical Transcription Vendor of Choice

Columbia Doctors, the Physicians and Surgeons of Columbia University select MxSecure, Inc., the nation's leading provider of medical transcription services to medical practices and healthcare clinics, as their transcription vendor of choice for the integration rollout of their electronic medical record.

Anavex Scales Up Synthesis of Anavex 2-73 for Phase 1 Alzheimer's Disease Study

Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) announces the signing of an agreement to scale up the synthesis of ANAVEX 2-73 for its Phase 1 Alzheimer's Disease study, which is scheduled to commence in 2009.Harvey Lalach, the president of Anavex, said this an important step towards the future development of ANAVEX 2-73 and the commencement of clinical trials. Mr. Lalach added that the company is pleased with its "progress to date with the compound, which shows enormous potential to modify and reverse the effects of Alzheimer's disease. We look forward to continued success as we move into our scheduled Phase 1 trials."

Stemedica Announces the Appointment of Dr. Michael Bayer as Director, Medical Services

Stemedica Cell Technologies, Inc., a leader in adult stem cell development, today announces that it has appointed Riccardo Nisato, MBA, PhD, as Director of Manufacturing and Clinical Business Development of Stemedica International, CH. Dr. Nisato will be responsible for replicating Stemedica's U.S. based operations to Stemedica's International's center based in Lausanne, Switzerland.

Pages: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 Next

Page 37 of 44